UroGen Pharma (URGN) Misses Q4 EPS by 4c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: URGN) | Delayed: 34.26 +0.22 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.04 | 52 Week High | $ | |||
| Open | $34.16 | 52 Week Low | $ | |||
| Day High | $34.50 | P/E | N/A | |||
| Day Low | $33.50 | EPS | $ | |||
| Volume | 545,560 | |||||
